CIK: 1741288 - Address: C/o Magenta Therapeutics, Inc., 100 Technology Square, 5Th Floor, Cambridge, MA 02139
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/2/19 20:29
12/2/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-9813.000-8-3241D
11/25/19 20:52
11/20/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-6012.000-5-2248D
11/1/19 20:02
11/1/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-5310.670-5-2253D
10/3/19 16:50
10/1/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-5010.010-5-2258D
9/19/19 16:26
9/19/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-2012.000-2-1263D
9/16/19 18:36
9/12/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-1012.000-10265D
9/4/19 17:06
9/3/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-5110.110-5-2266D
8/1/19 16:14
8/1/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-10113.420-8-3271D
7/2/19 10:51
7/1/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-10814.400-8-3278D
6/18/19 17:18
6/17/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooke Michael P.MAOChief ScS-10413.900-8-3286D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact